Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 27, 2019
Chiesi USA will occupy the top two floors of Regency Woods II, a six-story development by The Spectrum Companies located off U.S. 64 near Symphony Lake in North Carolina.
read more
Fortress Biotech announced Oncogenuity has an agreement with Columbia University to develop novel oligonucleotides for the treatment of genetically driven cancers.
read more
Catalent has signed an agreement with Spicona to develop a virus-like protein (VLP)-based vaccine against COVID-19.
read more
Wednesday, October 03, 2018
Trovagene has entered into an exclusive patent license agreement with the Massachusetts Institute of Technology (MIT).
read more
Wednesday, December 26, 2018
DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera from using DUSA's confidential and proprietary trade secret information.
read more
Monday, December 30, 2019
Sensyne Health has signed a research project with Roche.
read more
Wednesday, August 19, 2015
Amgen will pay $71 million to settle an investigation into illegal marketing of its drugs Aranesp and Enbrel, ending an investigation by 48 states and Washington DC.
read more
Wednesday, March 23, 2016
Lundbeck, a global pharmaceutical company, has chosen ArisGlobal® to complete the upgrade of its regulatory and safety systems on the agOnDemand™ platform.
read more
Thursday, February 27, 2025
LSPedia has secured its second major U.S. government contract, the MMCAP Infuse DSCSA Compliance contract. This follows its national DSCSA contract with the U.S. Department of Veterans Affairs, further solidifying LSPedia's leadership position in the...
read more
Mylan lowered the bar for shareholder approval in its ongoing hostile bid for rival pharmaceutical company Perrigo.
read more
Simulations Plus has entered into a new funded collaboration with a large pharmaceutical company to develop the Virtual Bioequivalence (BE) Trial Simulator™ in GastroPlus®.
read more
Omnicell announced that St. Luke’s University Health Network has awarded the Company a five-year contract to provide automation solutions that will support medication management across the health system.
read more
Thursday, August 08, 2024
The Government of Canada , represented by Charles Sousa, Parliamentary Secretary to the Minister of Public Services and Procurement, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a ...
read more
Tuesday, December 29, 2020
vTv Therapeutics has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.
read more
Appointment strengthens the financial and corporate experience of Metrion’s Board in support of the Company’s planned international growth.
read more